BIOMAT Database Logo BIOMAT Database Logo

Sulphinpyrazone (Anturan) after myocardial infarction. 1979

M R Nicholson, and R M Whitlock

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone

Related Publications

M R Nicholson, and R M Whitlock
Sulphinpyrazone (Anturan) after myocardial infarct.
October 1979, The New Zealand medical journal,
M R Nicholson, and R M Whitlock
Sulphinpyrazone in post-myocardial infarction. Report from the Anturan Reinfarction Italian Study.
January 1982, Lancet (London, England),
M R Nicholson, and R M Whitlock
Sulphinpyrazone after myocardial infarction.
June 1978, British medical journal,
M R Nicholson, and R M Whitlock
Sulphinpyrazone after myocardial infarction.
March 1978, Lancet (London, England),
M R Nicholson, and R M Whitlock
Sulphinpyrazone after myocardial infarction.
April 1978, Lancet (London, England),
M R Nicholson, and R M Whitlock
[Sulfinpyrazone (Anturan) after myocardial infarction].
September 1980, Ugeskrift for laeger,
M R Nicholson, and R M Whitlock
Sulphinpyrazone and warfarin after myocardial infarction.
August 1979, British medical journal,
M R Nicholson, and R M Whitlock
Sulphinpyrazone and warfarin after myocardial infarction.
July 1979, British medical journal,
M R Nicholson, and R M Whitlock
Sulphinpyrazone and myocardial infarction.
January 1981, Current medical research and opinion,
M R Nicholson, and R M Whitlock
Sulphinpyrazone and prevention of death after myocardial infarction.
August 1978, British medical journal,
Copied contents to your clipboard!